Krilogy Financial LLC increased its position in shares of CVS Health Co. (NYSE:CVS – Get Rating) by 1.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,075 shares of the pharmacy operator’s stock after purchasing an additional 108 shares during the period. Krilogy Financial LLC’s holdings in CVS Health were worth $841,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Macroview Investment Management LLC lifted its holdings in CVS Health by 128.3% during the 1st quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 136 shares in the last quarter. Claremont Financial Group Inc. bought a new stake in shares of CVS Health in the 4th quarter valued at about $26,000. Stuart Chaussee & Associates Inc. raised its holdings in shares of CVS Health by 123.0% in the 1st quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 171 shares in the last quarter. Rise Advisors LLC bought a new stake in shares of CVS Health in the 4th quarter valued at about $41,000. Finally, Carl Stuart Investment Advisor Inc. bought a new stake in shares of CVS Health in the 1st quarter valued at about $41,000. Institutional investors own 77.64% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CVS Health from $113.00 to $120.00 in a report on Thursday, August 4th. Sanford C. Bernstein downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $122.00 to $112.00 in a research report on Thursday, May 26th. Mizuho boosted their target price on shares of CVS Health from $115.00 to $120.00 and gave the stock a “buy” rating in a research report on Monday, August 15th. Tigress Financial upped their price objective on shares of CVS Health from $125.00 to $130.00 in a report on Wednesday, August 17th. Finally, UBS Group boosted their target price on shares of CVS Health from $118.00 to $127.00 and gave the company a “buy” rating in a research note on Thursday, August 4th. Four equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $117.59.
Insiders Place Their Bets
CVS Health Trading Up 0.1 %
Shares of CVS stock opened at $99.83 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.91 and a quick ratio of 0.65. The firm has a market cap of $131.06 billion, a PE ratio of 16.23, a price-to-earnings-growth ratio of 1.52 and a beta of 0.73. The company has a 50-day moving average of $100.14 and a two-hundred day moving average of $99.28. CVS Health Co. has a 1-year low of $81.78 and a 1-year high of $111.25.
CVS Health (NYSE:CVS – Get Rating) last announced its earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share for the quarter, topping the consensus estimate of $2.16 by $0.24. The company had revenue of $80.64 billion during the quarter, compared to analyst estimates of $76.38 billion. CVS Health had a net margin of 2.65% and a return on equity of 15.19%. CVS Health’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $2.42 earnings per share. On average, analysts predict that CVS Health Co. will post 8.53 EPS for the current year.
CVS Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 1st. Shareholders of record on Friday, October 21st will be paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 2.20%. CVS Health’s dividend payout ratio (DPR) is presently 35.77%.
CVS Health Profile
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- The Institutions Hold On To Darden Restaurants International
- What Steelcase’s Earnings Say About the Return to the Office?
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.